PHARMA 4
ActiveDirectors
Directors
1 director, last change in 2024
Board 1
AWM PHARMA
Current
Director · current term since 01-07-2024 · Legal entity · permanent representative: WAHIB MOUSSA Asmaa · listed in the 2025 annual accounts, filed on 01-07-2026
Permanent representatives 1
WAHIB MOUSSA Asmaa
Current
Permanent representative · appointed in the act of 19-07-2024 · for AWM PHARMA
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 13. Pouvoir de représentation Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit…”
deed of 19-10-2023Owners and capital
Shareholders
1 ownerChain of control
- AWM PHARMA
- PHARMA 4
Owners 1
- AWM PHARMAparentSourceaccounts AWM PHARMA 2025Equity €326,211 Profit of €158,417 in 2025 (profit of €67,794 in 2024)100%
Capital transactions
Capital over time
- 19-10-2023 Converted to unavailable equity · €8,060
Mandate history
5 people, 1 in office
- Board
- began earlier
- end not dated
| Name | Functions and periods |
|---|---|
| AWM PHARMA |
|
| Annie COENS |
|
| Eric VANOBBERGEN |
|
| COENS Annie Lucy Ghislaine |
|
| VANOBBERGEN Eric Jacques |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “1, organe d'administration”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant et moitié acquéreurs au prorata si plusieurs, toutes cessions entre vifs à titre onéreux ou gratuit,volontaires ou…”
Articles of association, deed of 19-10-2023 (in French)